Tuesday, August 12, 2026 · 4:00 PM IST
Event Participants
Executives
6
Anshul Khadwalia, Navpreet Kaur, Ranbir Singh Khadwalia, Shubham Khadwalia, SM Singla, Varun Sarma
Analysts
6
Amira Patel, Asha Sani, Manas, Omkar, Rahul Gupta, Sandesh Kumar, Shivshankar, Yogesh
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Revenue from Operations | ₹104.93 crores | +14.98% YoY vs ₹91.26 crores; growth driven primarily by tractor segment |
| EBITDA | ₹13.09 crores | +10.8% YoY vs ₹11.81 crores; margin ~12.5% |
| Tractor Segment Revenue | ₹52.08 crores | +36.29% YoY vs ₹38.21 crores; strongest growth driver in Q1 |
| Crane Segment Revenue | ₹52.86 crores | ~Flat YoY vs ₹53.05 crores; impacted by TRUM 3→5 emission norm transition and full capacity utilization |
| Tractor Capacity Utilization | 35-40% | Assembly line; machine shop utilization higher at 80-85% due to in-house crane component manufacturing |
| EBITDA Margin Guidance (FY27) | 12.5% - 13% | Standalone basis; implied from Q1 performance and management guidance |
Table Notes:
- Revenue growth of ~15% came below the company's 20-25% annual guidance, with crane flatness offsetting tractor strength
- Unit volume data for both segments not disclosed on call; management committed to sharing via email follow-up
Geographic & Segment Commentary
Tractors: Revenue grew 36.29% YoY to ₹52.08 crores. Company manufactures 16HP to 100HP (100HP under testing), with full range available in 4WD. Over 1 lakh tractors sold since inception. Capacity of ~12,000 units remains unchanged; utilization at 35-40% assembly/manufacturing levels. Growth trajectory of 35%+ for 3 consecutive quarters driven by expanded dealer network and village-level product demonstrations. Dealer count at ~225; company targeting 60+ additional dealers, with execution expected over 12-18 months.
Cranes: Revenue flat at ₹52.86 crores. Impacted by TRUM 3 to TRUM 5 emission norm transition which suppressed industry-wide demand and by capacity constraints at existing plant. Machinery in existing plant running at full capacity; production declining in Q1 due to emission shift, but July-August order response improving. Company expects 15-20% growth for FY27 from existing facility, with price hikes being implemented in Q2. Current dealer count at 20-25; expansion plan to 60+ dealers over 12-18 months lined up as new capacity comes online. Peer comparison: Escorts sells at premium pricing; one other competitor sells at similar price points.
Company-Specific & Strategic Commentary
New Plant at Bhud: Civil construction of main shed and pre-engineered buildings in full swing. Major machinery orders placed, machines ready; commercial production expected by end of November 2026, with equipment installation beginning October. Capital expenditure of ~₹45 crores still deposited in banks; capex deployment scheduled through March, with some deferral possible depending on supplier pricing.
Tower Cranes: Successfully developed and tested first prototype, clearing evaluations on structural integrity, operational efficiency, reliability, and safety. Initial production of 10 units planned at existing facility in current quarter, subject to receipt of certain imported components. Full commercial production line will be at new plant.
Dealer Network Expansion: Total dealer count at 250+ (225 tractor, 20-25 crane). Company replacing non-performing dealers and adding new ones in anticipation of new plant capacity. Target of 60+ additional dealers across both segments, though management cautions selection of right partners takes time - possibly 12-18 months to reach target levels.
Financing Support via NBFC: Bharata Finance financing ~20% of new Indo Farm tractors; also financing old tractors of all brands through exchange scheme from dealer inventory. Post-IPO capital injection into NBFC supporting retail financing - a key growth enabler.
Product Differentiation: In-house production (50%+ of tractor components) enables competitive pricing and customization advantages. Village-level mass demonstrations for tractors; crane products well-accepted where present, with major market share in served regions.
Export Initiative: Management noted export development underway as long-term growth support.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Overall Revenue Growth (FY27) | 20-25% | From existing plant only; assumes tractor momentum continues and crane recovers from H2 |
| Tractor Revenue Growth (FY27) | 25-30% | Supported by dealer additions, financing support, and demand recovery post-emission norm transition |
| Crane Revenue Growth (FY27) | 15-20% | From existing capacity; Q1 flat is temporary, July-August response encouraging; price hikes support value growth |
| EBITDA Margin (FY27) | 12.5-13% standalone | Q2 onward margin normalization expected as cost pass-through completes |
| Consolidated EBITDA (FY27) | Similar to last year (~14-15%) | Finance Head clarified consolidated adds NBFC lines; management confirmed directionally |
| New Plant Utilization (Year 1) | ~30% of 3,600 crane capacity | Ramp-up planned: 30% in Q1, 35-40% next quarter, 40-45% average in FY28 |
| New Plant Commercial Production | November 2026 | Subject to civil work completion and machinery installation |
| 3-5 Year CAGR (Tractors) | 30%+ | Management confident given product range, market expansion, and financing support |
| 3-Year New Plant Utilization (Cranes) | 70-80% | Management hopeful dependent on market conditions |
Risks & Constraints
| Risk | Context |
|---|---|
| Crane Segment Stagnation | Flat performance in Q1 due to TRUM 5 emission norm transition and capacity constraints. Management expects normalization from Q2; however, sustained weakness would impact overall growth target of 20-25% |
| Capacity Absorption Risk | New plant at Bhud adds 3,600 crane units against current ~1,000-1,200 capacity. Dealer expansion to 60+ is planned but management acknowledges takes 12-18 months to find right partners; initial utilization expected only ~30% |
| Input Cost Pressure & Price Pass-Through | Cost increases from emission norm transition impacted Q4 margins. Management indicates price hikes being implemented in Q2 as demand improves; competitive dynamics could limit pass-through ability |
| Component Import Dependency | Tower crane and certain machinery components sourced from abroad; receipt timing could slip commercial production timelines and initial 10-unit batch delivery |
| New Plant Execution Risk | Timeline for November commercial production dependent on civil work completion, machinery installation in October, and supplier readiness; capex deployment could be deferred if supplier pricing changes |
Q&A Highlights
Margin Recovery & Cost Pass-Through
- Question: Have cost increases from emission norm transition been fully passed to customers? When will margins normalize? (Rahul Gupta)
- Answer: Margin normalization from Q2 as demand improves; emission change from TRUM 3 to TRUM 5 took 3/4 quarters to stabilize. Price hikes being taken in Q2 across crane; tractor pricing follows industry. (Ranbir Singh Khadwalia)
Tower Crane Production & Commercial Timeline
- Question: Tower crane delivery was guided for Q2 FY27 - how is the order pipeline given November commercial production timeline? (Rahul Gupta)
- Answer: Prototype complete and tested. Manufacturing in-house components; 10 machines first lot expected within current quarter, subject to receipt of imported components. New plant machinery installation from October; commercial production by November. (Ranbir Singh Khadwalia)
Capacity Utilization & Dealer Strategy
- Question: How will 1,280 to 5,000 crane capacity be absorbed with stagnant dealer base (~20-25 since IPO)? Any plans for South India specifically? (Sandesh Kumar)
- Answer: Crane sales flat due to full existing plant capacity; new plant will phase in. Roadmap for 60+ dealers covering whole country, but right partner identification takes time - possibly 12-18 months. Current dealers also have headroom - can increase order volumes without new appointments. Existing dealers being evaluated; non-performers replaced. (Shubham Khadwalia, EVP Sales & Marketing)
Revenue Growth Guidance & Consolidation
- Question: Can you give Q2 and full year guidance? What is EBITDA margin guidance? (Manas)
- Answer: 20-25% overall growth from old plant; new plant contribution only considered from Q4. EBITDA margin 12.5-13% standalone; consolidated similar to last year at ~14-15% as NBFC lines run parallel. (Ranbir Singh Khadwalia; SM Singla provided consolidated clarification)
Unit Volumes & Utilization Details
- Question: Can you share Q1 volumes for tractors and cranes with YoY changes? (Asha Sani)
- Answer: Management stated numbers would be shared via email post-call, not disclosed during Q&A session. Assembly capacity utilization at 35-40%; machine shop 80-85% utilized due to in-house crane components manufacturing. (Ranbir Singh Khadwalia, SM Singla)
Product USP & Competitive Positioning
- Question: How do you differentiate in tractors and what is stopping faster scale-up? (Yogesh)
- Answer: Tractor range 16HP-100HP (100HP under testing), complete 4WD availability, competitive pricing due to backward integration, all Indian customer features at par with major players. Village-level mass demonstrations being conducted, leveraging 1 lakh+ tractors sold since inception. Scale-up constrained by dealer network creation - customer decisions involve 10-year service commitment; neighborhood influence matters. (Anshul Khadwalia, JMD)
Capex Utilization Timeline
- Question: Will ₹45 crores in bank deposits be utilized by Q3 to achieve commercialization by January? (Sandesh Kumar)
- Answer: Machine procurement phased - 6-8 machines instead of 10 (sufficient for 5,000 crane production) extends timeline. All machines ready; deployment through March, possibly deferred 3 months if supplier increases pricing. (Ranbir Singh Khadwalia)
Key Takeaway
Indo Farm Equipment reported Q1 FY27 revenue of ₹104.93 crores (+14.98% YoY), with EBITDA of ₹13.09 crores (margin ~12.5%). The tractor segment drove growth at +36.29% YoY to ₹52.08 crores, while crane revenue remained flat at ₹52.86 crores due to emission norm transition and capacity constraints at the existing plant — a temporary drag management expects to reverse from Q2 as price hikes and demand recovery take effect. Strategic focus centers on commissioning the new Bhud plant (3,600 crane units capacity) by November 2026, with deployment of ~₹45 crores capex through March, alongside tower crane production launch following successful prototype testing. Dealer network expansion to 60+ additional outlets across both segments is underway, with management acknowledging right-partner selection will take 12-18 months. FY27 guidance stands at 20-25% overall revenue growth, split between 25-30% tractors and 15-20% cranes, with EBITDA margin guidance of 12.5-13% standalone. Key watch items include crane demand recovery pace, new plant timeline adherence, and dealer absorption of expanded capacity amid financing support from NBFC subsidiary (20% of new tractor penetration). Management expressed confidence in sustained 30%+ tractor growth and 70-80% new plant utilization within 3 years, with export development adding long-term optionality.